Bevacizumab Treatment for Choroidal Neovascularization Associated with Adult-Onset Foveomacular Vitelliform Dystrophy

Abstract

Bevacizumab therapy for AOFVD-associated CNV resulted in reduced foveal thickness, but a guarded visual outcome was still found, due to progression of the vitelliform lesions.